Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
60 participants
OBSERVATIONAL
2024-05-22
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Performance of the New Plasma Filter PX2 in TPE Treatments
NCT06382675
Evaluation of Therapeutic Plasma Exchange (TPE) Procedure Using the AMICUS Device
NCT01210716
TPE in Rennes Hospital
NCT03888417
A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia
NCT04278924
Efficacy and Safety of IVIG-L in ITP Patients
NCT00151840
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The site will document the treatment data of patients with an indication for the TPE treatment who had been treated with the investigational devices under the TPE treatment mode between 2019 and October 2023 in chronological order.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TPE Treatments
Patients with indication for TPE treatment according to American Society for Apheresis (ASFA) guideline
Therapeutic Plasma Exchange (TPE) option of multiFiltratePRO
Retrospective Data Analysis of TPE treatments with multiFiltratePRO
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Therapeutic Plasma Exchange (TPE) option of multiFiltratePRO
Retrospective Data Analysis of TPE treatments with multiFiltratePRO
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with indication for TPE treatment according to ASFA guideline
* Patients have been treated with TPE between January 2019 and October 2023
* Availability of at least 50% of the parameters to be documented for the patient
Exclusion Criteria
* Previous documentation within this study
* Simultaneous use of another filter for additional therapy form
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
X-act Cologne Clinical Research GmbH
INDUSTRY
Fresenius Medical Care Deutschland GmbH
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stefan Büttner, Dr. med.
Role: PRINCIPAL_INVESTIGATOR
Klinikum Aschaffenburg-Alzenau
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Klinikum Aschaffenburg-Alzenau
Aschaffenburg, Bavaria, Germany
Universitätsklinikum Würzburg
Würzburg, Bavaria, Germany
Charité-Universitätsmedizin Berlin
Berlin, State of Berlin, Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CRRT-TPE-01-DE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.